These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36313312)

  • 1. Population pharmacokinetic analysis, renal safety, and dosing optimization of polymyxin B in lung transplant recipients with pneumonia: A prospective study.
    Cai XJ; Chen Y; Zhang XS; Wang YZ; Zhou WB; Zhang CH; Wu B; Song HZ; Yang H; Yu XB
    Front Pharmacol; 2022; 13():1019411. PubMed ID: 36313312
    [No Abstract]   [Full Text] [Related]  

  • 2. Population pharmacokinetic analysis and dosing optimization of colistin sulphate in lung transplant recipients with pneumonia: A prospective study.
    Cai X; Chen Y; Fu J; Chen Y; Shi L; Chen C; Zhang C; Zhou S; Zhou W; Wu B; Yang H; Yu X
    Int J Antimicrob Agents; 2024 Nov; 64(5):107346. PubMed ID: 39341362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy.
    Yu XB; Zhang XS; Wang YX; Wang YZ; Zhou HM; Xu FM; Yu JH; Zhang LW; Dai Y; Zhou ZY; Zhang CH; Lin GY; Pan JY
    Front Pharmacol; 2022; 13():915958. PubMed ID: 35784679
    [No Abstract]   [Full Text] [Related]  

  • 4. Population pharmacokinetic and optimization of polymyxin B dosing in adult patients with various renal functions.
    Yu XB; Jiao Z; Zhang CH; Dai Y; Zhou ZY; Han L; Wen X; Sheng CC; Lin GY; Pan JY
    Br J Clin Pharmacol; 2021 Apr; 87(4):1869-1877. PubMed ID: 33002196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetics of Polymyxin B and Dosage Optimization in Renal Transplant Patients.
    Li Y; Deng Y; Zhu ZY; Liu YP; Xu P; Li X; Xie YL; Yao HC; Yang L; Zhang BK; Zhou YG
    Front Pharmacol; 2021; 12():727170. PubMed ID: 34512352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients.
    Hanafin PO; Kwa A; Zavascki AP; Sandri AM; Scheetz MH; Kubin CJ; Shah J; Cherng BPZ; Yin MT; Wang J; Wang L; Calfee DP; Bolon M; Pogue JM; Purcell AW; Nation RL; Li J; Kaye KS; Rao GG
    Clin Microbiol Infect; 2023 Sep; 29(9):1174-1181. PubMed ID: 37217076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant
    Yu Z; Liu X; Du X; Chen H; Zhao F; Zhou Z; Wang Y; Zheng Y; Bergen PJ; Li X; Sun R; Fang L; Li W; Fan Y; Wu H; Guo B; Li J; Yu Y; Zhang J
    Front Pharmacol; 2022; 13():975066. PubMed ID: 36588676
    [No Abstract]   [Full Text] [Related]  

  • 8. Population pharmacokinetics of polymyxin B and dosage strategy in critically ill patients with/without continuous renal replacement therapy.
    Luo X; Zhang Y; Liang P; Zhu H; Li M; Ding X; Zhang J
    Eur J Pharm Sci; 2022 Aug; 175():106214. PubMed ID: 35609779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study.
    Tang T; Li Y; Xu P; Zhong Y; Yang M; Ma W; Xiang D; Zhang B; Zhou Y
    Crit Care; 2023 Apr; 27(1):164. PubMed ID: 37106370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The population pharmacokinetics and dose optimization of polymyxin B in critically ill patients with or without extracorporeal membrane oxygenation.
    Ye Q; Wang Q; Chen W; Zhang R; Chen Z; Li P; Zhang X; Zhan Q; Wang C
    J Clin Pharm Ther; 2022 Oct; 47(10):1608-1618. PubMed ID: 35716048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of polymyxin B AUC/MIC ratio for dose optimization in patients with carbapenem-resistant
    Wang P; Liu S; Qi G; Xu M; Sun T; Yang J
    Front Microbiol; 2023; 14():1226981. PubMed ID: 37675417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of polymyxin B and proposed dosing regimens in elderly patients with multi-drug-resistant Gram-negative bacterial infections.
    Wang P; Liu D; Sun T; Zhang X; Yang J
    Int J Antimicrob Agents; 2022; 60(5-6):106693. PubMed ID: 36375775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic analysis and dosing optimization of polymyxin B in critically ill patients.
    Liang D; Liang Z; Deng G; Cen A; Luo D; Zhang C; Ni S
    Front Pharmacol; 2023; 14():1122310. PubMed ID: 37063299
    [No Abstract]   [Full Text] [Related]  

  • 14. Population Pharmacokinetics of Polymyxin B in Obese Patients for Resistant Gram-Negative Infections.
    Wang P; Zhang Q; Feng M; Sun T; Yang J; Zhang X
    Front Pharmacol; 2021; 12():754844. PubMed ID: 34880755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of polymyxin B in patients with liver dysfunction.
    Li X; Cheng Y; Chen B; Chen Y; Huang Y; Zhang B; Que W; Liu M; Zhang H; Qiu H
    Br J Clin Pharmacol; 2023 Dec; 89(12):3561-3572. PubMed ID: 37461291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration.
    Wang P; Xing H; Zhang F; Liu S; Lu Y; Zhang X; Yang J; Sun T
    Int J Antimicrob Agents; 2022 Jul; 60(1):106599. PubMed ID: 35526750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis.
    Xu H; Zhou W; Zhou D; Li J; Al-Huniti N
    J Clin Pharmacol; 2017 Mar; 57(3):336-344. PubMed ID: 27530649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily fluid intake as a novel covariate affecting the population pharmacokinetics of polymyxin B in patients with sepsis.
    Wang P; Liu S; Sun T; Yang J
    Int J Antimicrob Agents; 2024 Mar; 63(3):107099. PubMed ID: 38280575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients.
    Xie YL; Jin X; Yan SS; Wu CF; Xiang BX; Wang H; Liang W; Yang BC; Xiao XF; Li ZL; Pei Q; Zuo XC; Peng Y
    Front Pharmacol; 2022; 13():967412. PubMed ID: 36105229
    [No Abstract]   [Full Text] [Related]  

  • 20. Population pharmacokinetics and clinical outcomes of polymyxin B in paediatric patients with multidrug-resistant Gram-negative bacterial infections.
    Wang PL; Liu P; Zhang QW; Yuan WH; Wang D; Zhang XJ; Yang J
    J Antimicrob Chemother; 2022 Oct; 77(11):3000-3008. PubMed ID: 35924405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.